DK1173153T3 - Orale farmaceutiske præparater, som indeholder langkædede triglycerider og lipofile overfladeaktive midler - Google Patents

Orale farmaceutiske præparater, som indeholder langkædede triglycerider og lipofile overfladeaktive midler

Info

Publication number
DK1173153T3
DK1173153T3 DK00919874T DK00919874T DK1173153T3 DK 1173153 T3 DK1173153 T3 DK 1173153T3 DK 00919874 T DK00919874 T DK 00919874T DK 00919874 T DK00919874 T DK 00919874T DK 1173153 T3 DK1173153 T3 DK 1173153T3
Authority
DK
Denmark
Prior art keywords
long chain
active ingredient
contain
drug
compositions
Prior art date
Application number
DK00919874T
Other languages
English (en)
Inventor
Nijs Henrik De
Elizabeth A Perry
Susan Chandler
Josephine Joan Chr Ferdinando
Original Assignee
Scherer Corp R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Corp R P filed Critical Scherer Corp R P
Application granted granted Critical
Publication of DK1173153T3 publication Critical patent/DK1173153T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK00919874T 1999-04-01 2000-03-29 Orale farmaceutiske præparater, som indeholder langkædede triglycerider og lipofile overfladeaktive midler DK1173153T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9907715.8A GB9907715D0 (en) 1999-04-01 1999-04-01 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
DK1173153T3 true DK1173153T3 (da) 2006-02-20

Family

ID=10850947

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00919874T DK1173153T3 (da) 1999-04-01 2000-03-29 Orale farmaceutiske præparater, som indeholder langkædede triglycerider og lipofile overfladeaktive midler

Country Status (23)

Country Link
EP (1) EP1173153B1 (da)
JP (1) JP4636692B2 (da)
AT (1) ATE311177T1 (da)
AU (1) AU763971B2 (da)
BR (1) BRPI0009373B8 (da)
CA (1) CA2366754C (da)
CZ (1) CZ301724B6 (da)
DE (1) DE60024429T2 (da)
DK (1) DK1173153T3 (da)
ES (1) ES2251991T3 (da)
GB (1) GB9907715D0 (da)
HK (1) HK1040364B (da)
HU (1) HU227155B1 (da)
IL (2) IL145567A0 (da)
MX (1) MXPA01009817A (da)
NO (1) NO331396B1 (da)
NZ (1) NZ514649A (da)
PL (1) PL196823B1 (da)
RU (1) RU2207859C1 (da)
SI (1) SI1173153T1 (da)
TR (1) TR200102861T2 (da)
WO (1) WO2000059482A1 (da)
ZA (1) ZA200108457B (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150374826A1 (en) * 1999-06-30 2015-12-31 Lipocine Inc. Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
AUPR573001A0 (en) * 2001-06-15 2001-07-12 Glaxo Wellcome Australia Ltd Lymphatic drug delivery system
US7125568B2 (en) 2001-08-23 2006-10-24 Sung Michael T Lipophilic drug compositions
KR100533458B1 (ko) 2002-07-20 2005-12-07 대화제약 주식회사 파클리탁셀의 가용화용 조성물 및 그의 제조 방법
KR100533460B1 (ko) * 2002-07-20 2005-12-08 대화제약 주식회사 난용성 약물의 가용화용 점막흡착성 조성물, 이를 이용한난용성 약물의 가용화용 제형 및 이들의 제조 방법
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
PL1660047T3 (pl) 2003-08-13 2014-05-30 Biocon Ltd Formulacje dawek stałych mikrocząsteczek soli kwasów tłuszczowych do środków terapeutycznych
US8492369B2 (en) 2010-04-12 2013-07-23 Clarus Therapeutics Inc Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
EP2979699A1 (en) * 2005-04-15 2016-02-03 Clarus Therapeutics, Inc. Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
CN1853728A (zh) * 2005-04-19 2006-11-01 上海天博生物科技有限公司 一种改善药物或营养物口服吸收的方法、配方及其应用
JP4889262B2 (ja) 2005-08-19 2012-03-07 理研ビタミン株式会社 脂溶性薬剤組成物
GB0807605D0 (en) * 2008-04-28 2008-06-04 Diurnal Ltd Lipid composition
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
IN2014MN02213A (da) 2012-05-10 2015-07-10 Painreform Ltd
US9801819B2 (en) 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
MX2015000217A (es) 2012-06-28 2015-04-10 Mcneil Ppc Inc Composiciones lipidicas de racecadotrilo.
ES2638981T3 (es) * 2012-12-20 2017-10-24 Solural Pharma ApS Forma de dosificación oral sólida del derivado de testosterona
WO2015100406A1 (en) 2013-12-26 2015-07-02 Clarus Therapeutics, Inc. Use of oral pharmaceutical products combining testosterone esters with hypolipidemic agents
US9925200B2 (en) * 2014-06-17 2018-03-27 Merck Sharp & Dohme B.V. Stable formulations of testosterone undecanoate
EA036836B1 (ru) 2014-06-19 2020-12-25 Солурал Фарма Апс Фармацевтическая композиция для обеспечения лимфатической абсорбции липофильных соединений после еды и натощак
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
AU2016284459B2 (en) 2015-06-22 2021-12-23 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
JP2020503269A (ja) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド 経口ウンデカン酸テストステロン療法
IL274893B1 (en) 2017-11-27 2024-04-01 Umecrine Cognition Ab Pharmaceutical formulation of 3 alpha-ethynyl-3 beta-hydroxyandrostan-17-one oxime

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5218811A (en) * 1975-08-01 1977-02-12 Eisai Co Ltd Preparation of aqueous solution of fat- soluble substances
JPS61221131A (ja) * 1985-03-28 1986-10-01 Eisai Co Ltd 吸収促進したユビデカレノン含有組成物
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
GB9608719D0 (en) * 1996-04-26 1996-07-03 Scherer Ltd R P Pharmaceutical compositions
WO2000059512A1 (en) * 1999-04-01 2000-10-12 Akzo Nobel N.V. Formulation comprising testosteron undecanoate and castor oil

Also Published As

Publication number Publication date
TR200102861T2 (tr) 2004-12-21
NO20014719D0 (no) 2001-09-28
HK1040364A1 (en) 2002-06-07
DE60024429T2 (de) 2006-08-03
NO331396B1 (no) 2011-12-12
SI1173153T1 (sl) 2006-06-30
HUP0201444A2 (hu) 2002-11-28
HU227155B1 (en) 2010-09-28
HK1040364B (zh) 2006-02-10
ES2251991T3 (es) 2006-05-16
DE60024429D1 (de) 2006-01-05
EP1173153A4 (en) 2002-01-30
BRPI0009373B1 (pt) 2015-09-01
PL196823B1 (pl) 2008-02-29
MXPA01009817A (es) 2002-07-30
IL145567A0 (en) 2002-06-30
CA2366754A1 (en) 2000-10-12
RU2001129365A (ru) 2004-02-20
ATE311177T1 (de) 2005-12-15
BR0009373A (pt) 2002-01-29
NZ514649A (en) 2003-09-26
ZA200108457B (en) 2004-02-12
EP1173153A1 (en) 2002-01-23
HUP0201444A3 (en) 2004-05-28
IL145567A (en) 2006-04-10
BRPI0009373B8 (pt) 2021-05-25
WO2000059482A1 (en) 2000-10-12
CA2366754C (en) 2009-07-14
PL350094A1 (en) 2002-11-04
JP4636692B2 (ja) 2011-02-23
CZ20013460A3 (cs) 2002-06-12
NO20014719L (no) 2001-10-24
AU763971B2 (en) 2003-08-07
GB9907715D0 (en) 1999-05-26
JP2003526620A (ja) 2003-09-09
EP1173153B1 (en) 2005-11-30
AU4049400A (en) 2000-10-23
CZ301724B6 (cs) 2010-06-02
RU2207859C1 (ru) 2003-07-10

Similar Documents

Publication Publication Date Title
DK1173153T3 (da) Orale farmaceutiske præparater, som indeholder langkædede triglycerider og lipofile overfladeaktive midler
KR100666016B1 (ko) 테스토스테론 운데카노에이트 및 피마자유를 포함하는 제제
DK0904064T3 (da) Orale farmaceutiske præparater indeholdende kønshormoner
FI20000171A (fi) Itse-emulgoituvan valmisteen muodossa oleva farmaseuttinen koostumus lipofiilisia yhdisteitä varten
CA2294031A1 (en) SELF-EMULSIFYING FORMULATION FOR LIPOPHILIC COMPOUNDS
ES2174814T3 (es) Acidos grasos esenciales destinados en la prevencion de accidentes cardio-vasculares.
PL318560A1 (en) Novel orally administered preparations containing cyclosporin of simple composition and high bioavailability
UY26303A1 (es) Composiciones farmacéuticas para administración oral y tópica
KR950031039A (ko) 경구 투여 약제용 제제
AR016629A1 (es) Una solucion que comprende un azaesteroide farmaceuticamente activo y un ester de acido graso de glicerol o propilen glicol, composiciones farmaceuticasque comprenden la solucion y capsulas de gelatina rellenas con la composicion farmaceutica.
MY130474A (en) Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants
ES2141049A1 (es) Formulaciones farmaceuticas en aerosol que contienen trigliceridos de cadena media como surfactantes.
TH18778A (th) สูตรผสมสำหรับสารทางเคมีเภสัชศาสตร์ที่ให้ทางปาก
JP2000159660A (ja) シクロスポリンカプセル剤
AR023235A1 (es) Formulaciones de androgenos